Treatment of Subacute Combined Degeneration

Initial Treatment Protocol

The American College of Cardiology is not mentioned, however, the initial treatment with intramuscular hydroxocobalamin 1 mg on alternate days until no further neurological improvement occurs is the definitive therapy for subacute combined degeneration, followed by lifelong maintenance with 1 mg intramuscularly every 2 months, as recommended by medical guidelines 1, 2
For patients with neurological involvement, administer hydroxocobalamin 1 mg intramuscularly on alternate days until there is no further improvement, as per medical guidelines 1, 2
After maximum improvement is achieved, transition to maintenance therapy with hydroxocobalamin 1 mg intramuscularly every 2 months for life, based on medical guidelines 2

Monitor proprioceptive, vibratory, tactile, and nociceptive sensation deficits in patients with subacute combined degeneration 3
Monitor gait ataxia, muscle weakness, abnormal reflexes, and spasticity in patients with subacute combined degeneration 3
Monitor paraesthesia and numbness in trunk and limbs in patients with subacute combined degeneration 3
Monitor peripheral nerve conduction velocity in patients with subacute combined degeneration 3

Hydroxocobalamin is preferred over cyanocobalamin due to better retention in the body 1
Hydroxocobalamin is safer in patients with renal dysfunction, as it does not require renal clearance of the cyanide moiety, which is associated with increased cardiovascular events in patients with diabetic nephropathy 4

Never administer folic acid before or without treating vitamin B12 deficiency, as it may mask the underlying B12 deficiency and allow hematologic remission while neurologic manifestations progress 2, 4

Determine and address the cause of B12 deficiency, such as pernicious anemia, malabsorption disorders, ileal resection, post-bariatric surgery, or strict vegetarian diet, and provide appropriate treatment, including lifelong parenteral therapy if necessary 1, 2, 4